What's Happening?
A study conducted by the University of Nebraska Medical Center has found a significant link between the use of certain medications during pregnancy and an increased risk of autism spectrum disorder (ASD) in children. The research, published in Molecular
Psychiatry, analyzed 6.14 million maternal-child health records from the Epic Cosmos database, covering nearly one-third of U.S. births from 2014 to 2023. The study identified that drugs disrupting cholesterol production pathways, including some antidepressants and statins, were associated with higher ASD rates. Pregnant individuals prescribed at least one of these medications had a 1.47 times higher likelihood of having a child with ASD, with the risk increasing with the number of medications used.
Why It's Important?
The findings of this study are significant as they highlight potential risks associated with commonly prescribed medications during pregnancy, affecting millions of prescriptions annually in the U.S. Cholesterol is crucial for fetal brain development, and disruptions in its production can lead to developmental disorders. This research underscores the need for healthcare providers to reassess prescribing practices for pregnant patients and consider safer alternatives. The study also calls for increased awareness among medical professionals about the potential impacts of these medications on fetal development.
What's Next?
The research team recommends developing a comprehensive list of drugs affecting sterol pathways and screening new medications for unintended cholesterol synthesis interference. They also suggest improving provider awareness and considering safer alternatives when necessary. Further research is needed to understand these mechanisms better and reduce risks. Pregnant patients are advised not to change medications without consulting healthcare providers.
